5,925 results on '"Hemorrhagic Fever, Ebola"'
Search Results
2. Natural History, Disease Progression, and Long-Term Neurologic Sequelae of Ebola Virus Disease (EVD) Survivors in PREVAIL III
3. African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
4. Immunology of Ebola Vaccine
5. Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination With the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC (EBO-BOOST)
6. Partnership for Research on Ebola VACcinations (PREVAC)
7. REVIVE (Response to the Ebola Virus Vaccine)
8. Open-Label Expanded Access for Ebola-Infected Patients to Receive Human mAb Ansuvimab as Therapeutic or for HR PEP
9. A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)
10. Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein
11. Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo
12. Ad26.ZEBOV Booster in Children Previously Vaccinated With Ad26.ZEBOV and MVA-BN-Filo (EBOVAC Booster Study)
13. Addressing Medium- to Long-term EBOLA Associated Psychological Distress and Psychosocial Problems in Central Uganda (Ebola+D)
14. A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants
15. Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study
16. R3470-3471-3479 (REGN-EB3) Expanded Access Protocol (EAP) for Treatment of Ebola Virus Disease
17. Solidarity/Tokomeza Ebola Trial (TOKOMEZA)
18. Community Preparedness for Outbreak Response and Readiness for Ebola Vaccination in Liberia
19. Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon (EBOLAPED)
20. A Study of a New Vaccine Against Two Types of Ebola
21. Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)
22. EBOVAC-Salone Extension
23. A Study in Tanzania of a New Vaccine Against Two Types of Ebola
24. Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola (EBOVAC3DRC)
25. Ebola Sudan Chimpanzee Adenovirus Vector Vaccine in Healthy Adults
26. Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up
27. PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response
28. Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults
29. Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo (EBOVAC-Salone)
30. INO-4201 as Booster in Healthy VSV-ZEBOV Vaccinees (Boost-EBOV)
31. Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults
32. Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)
33. Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo
34. GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen
35. Pilot Study Evaluating the Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers
36. Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects
37. Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC
38. Prophylaxis Vaccine Antibodies Ebola (PROVAE)
39. Investigational Therapeutics for the Treatment of People With Ebola Virus Disease
40. ZEBOVAC (Ebola Vaccine Trial, Ad26.ZEBOV/MVA-BN-Filo)
41. A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease
42. Observational Study of the Clinico-biological Evolution and Standard of Care Offered to Patients With Ebola Virus Disease (EVISTA)
43. Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)
44. An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease
45. A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults
46. Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC (MobEboDRC)
47. International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi
48. Piloting Clinical Bacteriology in the Ebola Virus Disease Care Response (Bact_EVD)
49. Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines (PRISM)
50. An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola (BCV EBOV)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.